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Abstract 
N-Ethylmaleimide-sensitive factor (NSF) mediates docking and/or fusion of transport vesicles in the multi-pathways of vesicular transport. NSF 
was highly expressed in brain and adrenal gland. Immunostaining of cerebellum with an anti-NSF monoclonal antibody showed that NSF is 
predominantly localized in the molecular layers and the glomeruli of the granule cell layers. This distribution coincided well with that of synaptophysin, 
a marker protein of synaptic vesicles. Purification and immunoprecipitation revealed that NSF is associated with brain synaptic vesicles. The present 
results suggest hat NSF is associated with synaptic vesicles without Ca” influx. 
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1. Introduction 
N-Ethylmaleimide-sensitive factor (NSF) was first 
characterized as a protein that mediates intra-Golgi pro- 
tein transport reconstituted in a cell-free system [1,2]. 
This protein is an N-ethylmaleimide-sensitive ATPase [3] 
and contains two homologous nucleotide-binding do- 
mains [3,4]. Site-directed mutagenesis study revealed that 
the two homologous regions are important for both 
ATPase and protein transport activities [5]. Several ines 
of evidence suggest that NSF most likely promotes fu- 
sion of freshly uncoated non-clathrin-coated vesicles 
with the target Golgi cisternae [6,7]. 
NSF forms a 20 S complex, which comprises, other 
than NSF, soluble NSF attachment proteins (SNAPS) 
and SNAP receptors (SNARES) [S]. By using a reconsti- 
tution system of the 20 S NSF complex, SBllner et al. [9] 
recently identified that syntaxin, SNAP-25, and synap- 
tobrevin are components of the SNARE complex. The 
localization of the three SNARES (syntaxin and SNAP- 
25 are present on the plasma membrane and synapto- 
brevin is on synaptic vesicles) made SGllner et al. [9] 
propose a docking model of synaptic vesicles with the 
plasma membrane via the 20 S NSF complex. According 
to their model, Ca*’ promotes the dissociation of synap- 
totagmin, a Ca*‘-binding protein in the synaptic vesicles, 
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from the SNARE complex, which allows the association 
of NSF with the SNARE complex via SNAP. Subse- 
quent hydrolysis of ATP by NSF causes the disassembly 
of the 20 S complex and triggers the fusion of synaptic 
vesicles with the plasma membrane [lo]. This hypothesis 
is quite an attractive explanation of the mechanism of 
Ca2+-regulated neurotransmitter secretion, but remains 
to be elucidated. It is known that NSF is present in 
membranes as well as in cytosol [2]. NSF may form the 
20 S complex on synaptic vesicles without Ca” influx. 
This idea was supported by the present observation that 
NSF is associated with synaptic vesicles. 
2. Materials and methods 
2.1. Materials 
An anti-NSF monoclonal antibody (MAb 2E5) was prepared as 
described previously [3]. A monoclonal antibody against synaptophysin 
(SY38) was purchased from Progen. Avidin-biotin-peroxidase com- 
plex (ABC) kits for immunostaining were purchased from Vector Lab- 
oratories. 
2.2. Light microscopy 
Adult male Sprague-Dawley rats were successively perfused from the 
left ventricle with the following solutions: Hanks’ solution @H 7.4) for 
2 min, Hanks’ solution (pH 7.4) containing 4% paraformaldehyde and 
0.1% glutaraldehyde for 10 min, and PBS containing 50 mM NH&I for 
5 min. The small brains were removed, cut, and frozen in liquid nitro- 
gen. Frozen sections were prepared with a cryostat and mounted on 
gelatin-coated glass slides. The sections were preincubated for 30 min 
in phosphate-buffered saline (PBS) containing 0.3% H,O, to inactivate 
endogenous peroxidase activity. For the staining of synaptophysin, this 
step was omitted because the H,Oz treatment significantly reduced 
immunoreactivity. The preincubated sections were immersed for 15 min 
in PBS containing 20% normal goat serum, 0.5% bovine serum albu- 
min, and 0.3% Triton X-100, and then incubated for 2 h with MAb 2E5, 
anti-synaptophysin antibody, or control mouse IgG. After washing 
with PBS containing 0.3% Triton X-100, the sections were incubated 
for 30 min with 5 fig/ml biotinylated goat anti-mouse IgG in PBS 
containing 0.5% bovine serum albumin and 0.3% Triton X-100 for 30 
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min. After washing with PBS, the biotinylated sections were incubated 
for 30 min with ABC in PBS I1 1.121 and develoned with 0.1% 3.3- 
diamino-benzidine in 50 mM &is-HCI (pH 7.4j containing 0.02% 
H,O,. The reaction was enhanced by the treatment of 0.1% aqueous 
OsO, for 1 min. 
2.3. Preparation of organelles 
Rat brain synaptosomal fractions and synaptic vesicles were pre- 
pared according to the method of Huttner et al. 1131. For the final 
purification step of synaptic vesicles, the permeation chromatography 
on controlled-pore glass was replaced by Sephacryl S-1000 chromatog- 
raphy. For experiments to characterize synaptic vesicle-associated 
NSF, peak fractions of synaptophysin on sucrose density gradient cen- 
trifugation were used. Golgi membranes from Chinese hamster ovary 
(CHO) cells were prepared as described by Balch et al. [14]. Crude 
synaptic vesicles were prepared from bovine brain as described by Kishi 
and Ueda [15]. 
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Fig. 1. Expression of NSF in various tissues. (A) Expression of mRNA 
for NSF in various human tissues. Each lane contained 2 pg of highly 
pure poly(A’) RNA from heart (lane l), brain (lane 2), placenta (lane 
3) lung (lane 4), liver (lane 5), skeletal muscle (lane 6), kidney (lane 7), 
and pancreas (lane 8). Arrows indicate the positions of markers. (B) 
Expression of NSF protein in various rat tissues. Rat tissue homoge- 
nates in 10 mM Tris-HCl (pH 7.5) containing 0.25 M sucrose and 1 mM 
phenylmethylsulfonyl fluoride were centrifuged at 1,000 x g for 10 min. 
The supematants (100 pg each) were subjected to SDS-PAGE with a 
10% gel and immunodetected with MAb 2E5. Brain (lane l), heart (lane 
2), kidney (lane 3), lung (lane 4), liver (lane 5), muscle (lane 6), pancreas 
(lane 7), spleen (lane 8) testis (lane 9), and adrenal gland (lane 10). 
Arrows indicate the positions of molecular weight markers, 
Fig. 2. Distribution of NSF in rat cerebellum. Rat cerebellum was 
immunostained by using a monoclonal antibody against synaptophysin 
(A) or NSF (2E5) (B and C). A and B, bar = 1 mm; C, bar = 0.1 mm. 
P, ML, and GL represent a Purkinje cell, the molecular layer, and the 
granule cell layer, respectively. An arrow indicates the location of a 
glomerulus in the granule cell layer. 
2.4. Northern blot analysis 
A human multiple Northern blot (Clontech) was prehybridized at 
65°C for 3 h in 5 x SSPE, 10 x Denhardt’s olution, 0.1 mg/ml freshly 
denatured salmon sperm DNA, and 2% SDS. Hybridization was con- 
ducted at 65°C overnight in the same solution plus a randomly “P- 
labeled probe (position 734-1228 of CHO NSF). The blot was washed 
twice at room temperature for 20 min in 2 x SSC containing 0.05% SDS 
and twice at 50°C for 20 min in the same solution, and then exposed 
to X-ray film. 
3. Results 
Northern blot analysis of human tissues showed that 
a 4.4-kb NSF mRNA is highly expressed in brain (Fig. 
1A). This length coincided well with that of CHO NSF 
[4]. Cloning and sequencing revealed that human brain 
NSF (2232 bp; GenBank accession number U03985) 
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Fig. 3. Electron micrograph illustrating the morphology of the synaptic 
vesicle fractions on sucrose density gradient centrifugation. 
Bar = 400 nm. 
shares 90% and 97% identity with CHO NSF in DNA 
and amino acid sequence, respectively [4]. Immunoblot- 
ting of rat tissues with MAb 2E5 confirmed the high 
expression of NSF protein in brain (Fig. lb). Adrenal 
gland also highly expressed NSF (Fig. 1B). 
We examined the distribution of NSF in rat cerebel- 
lum and compared it with that of synaptophysin, a 
marker protein of synaptic vesicles. Synaptophysin was 
predominantly localized in molecular layers where nerve 
endings are concentrated (Fig. 2A). The distribution of 
NSF (Fig. 2B) was quite similar to that of synapto- 
physin. At high magnification, immunoreactivity was 
observed in glomeruli of granule cell layers and presyn- 
aptic terminals around the dendrites of Purkinje cells 
(Fig. 2C). The presence of NSF in the soma of Purkinje 
cells was not significant, although the Golgi apparatus 
is located in the cell body. This may reflect the lower 
density of NSF in the Golgi regions compared with the 
nerve endings. 
To investigate whether NSF is associated with synap- 
tic vesicles, the vesicles were purified from rat brain by 
the method of Huttner et al. [13] and immunodetected 
with MAb 2E5. It is known that synaptic vesicles from 
rat brain can be purified to near homogeneity by this 
method. First, a synaptosomal fraction was obtained by 
differential centrifugation of the brain homogenate. Syn- 
aptic vesicles were further purified by differential centrif- 
ugation and sucrose density gradient centrifugation after 
hypoosmotic lysis of the synaptosomes. Electron micro- 
scopic analyses revealed that the synaptic vesicles thus 
prepared are highly homogeneous (Fig. 3). Minor con- 
taminants in this preparation were removed by gel-per- 
meation on Sepharcryl S-1000. As expected, this step 
gave essentially one protein peak (Fig. 4A). Immunoblot 
analysis revealed that NSF was co-purified with synapto- 
physin (Fig. 4B). The content of NSF in rat synaptic 
vesicles was about 0.5% of total synaptic vesicle proteins. 
This content was about 2-fold higher than that of NSF 
in CHO Golgi membranes (data not shown). The enrich- 
ment of the vesicle marker protein synaptophysin was 
estimated by immunoblotting to be approximately 14- 
fold over the homogenate (data not shown), which is 
comparable to the values reported previously [16,17]. 
Immunoprecipitation of synaptic vesicles confirmed 
the association of NSF with synaptic vesicles (Fig. 5). 
The precipitate by anti-synaptophysin antibody-at- 
tached beads contained NSF as well as synaptophysin. 
Control antibody-attached beads precipitated a small 
amount of synaptic vesicles, but the amount was as much 
as that of the precipitate by uncoated beads. 
NSF is dissociated from Golgi membranes by a proc- 
ess coupled with ATP hydrolysis [l]. This reflects the 
disassembly of the 20 S complex consisting of NSF, 
SNAPS, and SNARES. We examined the effect of Mg2+- 
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Fig. 4. Puritication of synaptic vesicles by Sephacryl S-1000 chromatog- 
raphy. Fractions containing synaptic vesicles on sucrose density gradi- 
ent centrifugation were applied to a Sephacryl S-1000 column (1.6 x 85 
cm) equilibrated with 5 mM HEPES (pH 7.2) containing 300 mM 
glycine. The column was developed by the same buffer at a flow rate 
of 10 mlih, and fractions (1.7 ml each) were collected. (A) Elution 
profile. (B) Aliquots of fractions were subjected to trichloroacetic acid 
precipitation followed by SDS-PAGE with a 10% gel. NSF and synap- 
tophysin (~38) were immunodetected by MAb 2E5 and an anti-synap- 
tophysin antibody, respectively. 
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ATP on the binding of NSF to synaptic vesicles. Fig. 6 
shows that NSF in synaptic vesicles is not released by 
Mg2+-ATP. In a control experiment using CHO Golgi 
membranes, NSF was released by ATP in a Mg”-de- 
pendent manner. These results suggest that the binding 
mode of NSF in synaptic vesicles is different from that 
of NSF in Golgi membranes. 
4. Discussion 
Northern blot and immunoblot analyses showed that 
NSF is highly expressed in brain. This observation is 
essentially the same as recent results by Piischel et al. 
[ 181. Immunocytochemical and biochemical analyses re- 
vealed that NSF is associated with synaptic vesicles. 
NSF associated with the vesicles was not released by 
Mg2+-ATP, the condition which favors the release of 
NSF from Golgi membranes [l]. This suggestes that the 
binding modes of NSF to the two membranes are differ- 
ent. Based on the kinetic experiments using a cell-free 
intra-Golgi protein transport assay, Wattenberg et al. 
[19] suggested that NSF is incorporated into transport 
vesicles in a way not to exchange with exogenously added 
NSF. Similar results were obtained by using mutant NSF 
proteins that significantly inhibit inn-d-Golgi protein 
transport [5]. There seems to be some mechanism to 
make NSF tightly bind to transport vesicles. 
By using a reconstitution system of the 20 S NSF 
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Fig. 5. Immunoprecipitation of synaptic vesicles with an anti-synapto- 
physin antibody. 1 ml of crude synaptic vesicle fractions (5 mg/ml) from 
bovine brain was gently stirred at 4°C overnight in the presence of 10 
,LL~ of IgG (anti-synaptophysin antibody (lane 2) or control mouse IgG 
(lane 3)) or absence of IgG (lane 4). 50 ,LLI of anti-mouse IgG-attached 
Dynabeads M-280 was added to the vesicle fractions and incubated at 
4°C for 2 h with stirring. The beads were magnetically separated from 
the solutions, washed with PBS, suspended in sample buffer, and sub- 
jected to SDS-PAGE with a 10% gel. NSF and synaptophysin (~38) 
were immunodetected by a mixture of MAb 2E5 and anti-synapto- 
physin antibody. As a marker, rat brain synaptic vesicles (IO pg) were 
immunodetected (lane 1). 
CHO Golgi S.V. 
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Fig. 6. Retention of NSF on synaptic vesicles in the presence of Mg*‘- 
ATP. CHO Golgi membranes or synaptic vesicles (100 ~1) in 25 mM 
HEPES (pH 7.2) containing 1 mM dithiothreitol, 0.1 M KCI, 0.3 M 
sucrose, and 2% polyethylene glycol 4000 plus 5 mM MgCI,-0.5 mM 
ATP or 2 mM EDTA-0.5 mM ATP were incubated on ice for 5 min. 
The mixtures were then centrifuged at 400,000 x g for 30 min. The 
supematants, concentrated by trichloroacetic acid precipitation, were 
subjected to SDS-PAGE with a 10% gel and analyzed by immunoblot- 
ting with MAb 2E5. The whole incubation mixture as a control (lane 
l), the Mg’+-ATP-supernatant (lane 2), and the EDTA-ATP-superna- 
tant (lane 3). 
complex, Sollner et al. [9] demonstrated that syntaxin, 
SNAP-25, and synaptobrevin are SNARES. Based on 
the finding that a-SNAP can displace synaptotagmin 
from the SNARE complex, they hypothesized that Ca” 
allows the interaction between SNAP and NSF by pro- 
moting the dissociation of synaptotagmin from the 
SNARE complex. Subsequent hydrolysis of ATP by 
NSF results in the disassembly of the 20 S complex, 
which promotes membrane fusion [lo]. O’Connor et al. 
[20] argued that this model cannot explain the rapid 
Ca”-triggered exocytosis. In addition, a Ca2’ require- 
ment was not demonstrated for the interaction between 
synaptotagmin and a-SNAP [lo]. O’Connor et al. [20] 
proposed an alternative model in which NSF and SNAP 
play a role in docking of synaptic vesicles into a prefu- 
sion state upon ATP hydrolysis by NSF, and then synap- 
totagmin binds to the 20 S complex in a conformation 
that can be regulated by Ca2’. According to their model, 
NSF should be present in the 20 S complex without Ca2’ 
influx. The present observation that NSF is associated 
with synaptic vesicles favors the latter model. 
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